|1.||Pepys, Mark B: 13 articles (09/2015 - 01/2002)|
|2.||Hawkins, Philip N: 10 articles (09/2015 - 11/2002)|
|3.||Hawkins, P N: 9 articles (02/2007 - 05/2000)|
|4.||Hutchinson, Winston L: 8 articles (10/2012 - 01/2002)|
|5.||Tennent, Glenys A: 6 articles (10/2012 - 06/2005)|
|6.||Pepys, M B: 6 articles (05/2002 - 05/2000)|
|7.||Gallimore, J Ruth: 5 articles (10/2012 - 06/2005)|
|8.||Gillmore, J D: 5 articles (07/2001 - 05/2000)|
|9.||Gillmore, Julian D: 4 articles (09/2015 - 06/2004)|
|10.||Merchant, Soroush: 4 articles (06/2013 - 12/2007)|
11/01/2002 - "Labelled serum amyloid P component studies thus make a unique contribution to the diagnosis and management of individual patients with systemic amyloidosis, and to systematic studies of existing and novel therapies. "
07/01/1998 - "Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis."
04/01/1998 - "Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value."
02/01/1993 - "This study describes the results of scintigraphy with iodine-123-labelled serum amyloid P component (SAP) as a means of establishing the distribution of organ involvement in amyloidosis. "
05/01/1991 - "Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis."
09/01/1994 - "Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo."
06/01/2013 - "In a further four mice that received human serum amyloid P component (SAP) followed by anti-human SAP antibody, a treatment to eliminate visceral amyloid deposits, ECV in the liver and spleen returned to baseline after therapy (p < 0.01). "
04/01/2012 - "Serum amyloid P component (SAP) is a highly conserved plasma protein named for its universal presence in amyloid deposits. "
03/01/2010 - "Serum amyloid P component (SAP) is a universal constituent of amyloid deposits and contributes to their formation and/or persistence. "
01/01/2010 - "Serum amyloid P component which stabilizes Aβ fibrils in cortical amyloid plaques and cerebrovascular amyloid deposits significantly potentiated the barrier-weakening effect of Aβ1-42. "
|3.||Alzheimer Disease (Alzheimer's Disease)
01/30/1995 - "The present study uses light and electron microscopy to compare the cerebral localization of amyloid P component in cases with (n = 19) and without (n = 15) Alzheimer's disease (AD). "
03/01/1988 - "A case of familial, atypical Alzheimer's disease: immunohistochemical study of amyloid P-component."
01/01/2012 - "Our observations support serum amyloid P component as a therapeutic target in Alzheimer's disease."
05/05/2009 - "Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component."
01/01/2008 - "Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease."
10/01/2001 - "Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies."
02/01/2016 - "CsSAP, a teleost serum amyloid P component, interacts with bacteria, promotes phagocytosis, and enhances host resistance against bacterial and viral infection."
01/01/2002 - "Influenza virus infection is not affected by serum amyloid P component."
10/01/1997 - "Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro."
02/01/2006 - "Serum amyloid P-component (SAP), a pentraxin, is known to play an important role in innate immunity to microbial infections; however, nothing is known about it during tuberculosis (TB). "
|5.||Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/01/2002 - "Structural, quantitative and functional comparison of amyloid P component in sera from patients with systemic lupus erythematosus and healthy donors."
07/01/2004 - "Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction."
04/01/2008 - "To study serum levels of serum amyloid P component (SAP) and SAP-DNA complexes in a population-based cohort of patients with systemic lupus erythematosus (SLE). "
04/01/2008 - "Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. "
12/01/2005 - "To determine the presence of raised titres of anti-serum amyloid P component (SAP) antibodies in patients with systemic lupus erythematosus (SLE) and to evaluate their correlation with clinical disease by the SLEDAI and clinical manifestations. "
|1.||Amyloid (Amyloid Fibrils)
|2.||Proteins (Proteins, Gene)
|4.||Serum Amyloid P-Component
|8.||Serum Amyloid A Protein (Serum Amyloid A)
|9.||Blood Proteins (Serum Proteins)
|10.||DNA (Deoxyribonucleic Acid)
|5.||Photochemotherapy (Photodynamic Therapy)